Abstract | INTRODUCTION: MATERIALS AND METHODS: We evaluated serum apolipoprotein B and apolipoprotein A1 levels in consecutive, statin-naïve, adult ischemic stroke patients admitted to an academic medical center in southern India. We evaluated for differences in the mean serum levels of apolipoprotein B, apolipoprotein A1, and the apolipoprotein B/A1 ratio between patients with ischemic stroke attributed to intracranial atherosclerotic disease, extracranial atherosclerotic disease, small vessel disease, and cardioembolism. In secondary analysis, we assessed for differences in these serum apolipoproteins between patients with moderate-severe intracranial atherosclerotic disease and extracranial atherosclerotic disease, irrespective of ischemic stroke subtype. RESULTS: DISCUSSION:
|
Authors | Rizwan Kalani, Soumya Krishnamoorthy, D Deepa, Srinivas Gopala, Dorairaj Prabhakaran, David Tirschwell, P N Sylaja |
Journal | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
(J Stroke Cerebrovasc Dis)
Vol. 29
Issue 4
Pg. 104670
(Apr 2020)
ISSN: 1532-8511 [Electronic] United States |
PMID | 32057650
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Chemical References |
- APOA1 protein, human
- APOB protein, human
- Apolipoprotein A-I
- Apolipoprotein B-100
- Biomarkers
|
Topics |
- Academic Medical Centers
- Adult
- Aged
- Apolipoprotein A-I
(blood)
- Apolipoprotein B-100
(blood)
- Biomarkers
(blood)
- Brain Ischemia
(blood, classification, diagnosis)
- Cross-Sectional Studies
- Female
- Humans
- India
- Male
- Middle Aged
- Severity of Illness Index
- Stroke
(blood, classification, diagnosis)
|